According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Medical Dialogues team speaks with the lead authors of the research, Dr. Disha Chakraborty and Dr. Abhishek De from the Department of Dermatology, Calcutta National Medical College and Hospital, West ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

Dr. Carrie Jose, in her latest Health and Wellness column, provides six natural ways to relieve arthritis pain - without meds ...

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

groninger, a German manufacturer of filling and closing machines for the pharmaceutical, consumer healthcare and cosmetics industries, is expanding its U.S. headquarters in Charlotte. groninger USA ...